Craig Crews Awarded the 2020 Heinrich Wieland Prize

Thanks to the results of his many years of research, Professor Craig M. Crews is making innovative new medicines possible. So-called PROTACs (proteolysis-targeting chimeras) activate a cell’s quality control system to target disease-causing proteins for degradation. These new active substances are intended to specifically destroy proteins that, until now, have been therapeutically impervious. For his ground-breaking research, Professor Crews has been awarded the 2020 Heinrich Wieland Prize.

For more on this story, visit Yale News